| dbo:abstract
|
- Lalita Ramakrishnan FRS FMedSci (born 1959) is an American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology (MRC LMB), where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist. (en)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:award
| |
| dbo:birthPlace
| |
| dbo:influencedBy
| |
| dbo:institution
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 20989 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:awards
| |
| dbp:birthPlace
| |
| dbp:caption
|
- Lalita Ramakrishnan at the Royal Society admissions day in London, July 2018 (en)
|
| dbp:cc
| |
| dbp:fields
| |
| dbp:influences
| |
| dbp:name
| |
| dbp:spouse
| |
| dbp:thesisTitle
|
- Abelson virus-transformed cells as models of early B lymphocyte differentiation (en)
|
| dbp:thesisUrl
| |
| dbp:thesisYear
| |
| dbp:url
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
| |
| dcterms:subject
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Lalita Ramakrishnan FRS FMedSci (born 1959) is an American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology (MRC LMB), where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
